By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Valacyclovir

Valacyclovir

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|595 words

Valacyclovir: Uses, Side Effects, and Safety Information

What is Valacyclovir?

Valacyclovir is an antiviral medication that belongs to a class of drugs called nucleoside analogs. It is primarily used to treat infections caused by herpes viruses, including genital herpes, cold sores, and shingles. This prescription medication works by stopping viral replication and reducing the severity and duration of outbreaks.

Uses

Valacyclovir is approved for several viral infections:

  • Genital herpes: Treatment of initial episodes and recurrent outbreaks, as well as suppressive therapy to reduce frequency of recurrences
  • Cold sores (herpes labialis): Treatment of oral herpes outbreaks to reduce healing time and symptom severity
  • Shingles (herpes zoster): Treatment in adults to reduce pain duration and accelerate healing of skin lesions
  • Chickenpox: Treatment in children and adolescents when started within 24 hours of rash onset
  • Prevention of cytomegalovirus: Used in certain organ transplant patients to prevent CMV infection

How it works

Valacyclovir is a prodrug that converts to acyclovir in the body after absorption. Once converted, acyclovir interferes with viral DNA synthesis by mimicking building blocks that herpes viruses need to replicate. This prevents the virus from multiplying and spreading to healthy cells, allowing the immune system to control the infection more effectively.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Nausea
  • Abdominal pain
  • Dizziness
  • Fatigue
  • Diarrhea
  • Skin rash
  • Constipation

Serious side effects requiring immediate medical attention:

  • Severe kidney problems (decreased urination, swelling, confusion)
  • Blood disorders (unusual bruising, bleeding, extreme fatigue)
  • Neurological effects (seizures, tremors, hallucinations)
  • Severe allergic reactions (difficulty breathing, facial swelling)
  • Thrombotic thrombocytopenic purpura (rare blood clotting disorder)

Warnings and precautions

  • Kidney function: Patients with kidney disease require dose adjustments, as valacyclovir is eliminated through the kidneys. Regular monitoring may be necessary.
  • Pregnancy and breastfeeding: Classified as pregnancy category B. Should only be used when benefits outweigh risks. The drug passes into breast milk in small amounts.
  • Immune system: Patients with compromised immune systems may require different dosing and closer monitoring due to increased risk of complications.
  • Hydration: Adequate fluid intake is important to prevent kidney problems, especially with high doses or in elderly patients.
  • Age considerations: Elderly patients may be more sensitive to side effects and may require dose adjustments based on kidney function.

Interactions

Several medications and substances can interact with valacyclovir:

  • Probenecid: Increases valacyclovir blood levels by reducing kidney elimination, potentially increasing side effects
  • Cimetidine: May increase valacyclovir concentrations by competing for kidney elimination pathways
  • Nephrotoxic drugs: Medications toxic to kidneys (like aminoglycosides) may increase risk of kidney damage when combined
  • Mycophenolate mofetil: Both drugs may have increased blood levels when used together in transplant patients
  • Tenofovir: May compete for kidney elimination, potentially affecting levels of both medications
  • Zidovudine: Potential for increased drowsiness and lethargy when used concurrently
  • Live vaccines: Antiviral medications may reduce effectiveness of live viral vaccines like varicella vaccine

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary by condition:

  • Genital herpes (initial episode): 1000 mg twice daily for 10 days
  • Genital herpes (recurrent episodes): 500 mg twice daily for 3 days
  • Genital herpes (suppressive therapy): 500-1000 mg once daily
  • Cold sores: 2000 mg twice daily for 1 day
  • Shingles: 1000 mg three times daily for 7 days

Dosages must be adjusted for patients with kidney impairment. Always follow your healthcare provider’s specific instructions, as individual dosing may vary based on medical history, kidney function, and other factors. Treatment is most effective when started as early as possible after symptom onset.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Valacyclovir." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/valacyclovir/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing…

Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Black Cohosh

By
Prof. Giorgi Pkhakadze
02/06/2026

Valproate

By
Prof. Giorgi Pkhakadze
02/06/2026

Garlic supplements

By
Prof. Giorgi Pkhakadze
02/06/2026

Solifenacin

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up